A Safety and Cognitive Function Study of EVP-6124 Versus Placebo in Subjects With Nicotine Dependence

NCT01480232 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

345

Enrollment

OTHER

Sponsor class

Stopped Study has been put on clinical hold by FDA

Conditions

Nicotine Dependence
Smoking Cessation

Interventions

DRUG: EVP-6124
DRUG: Placebo Capsule
DRUG: NicoDerm Patch (Active)
DRUG: NRT Patch (Placebo)
BEHAVIORAL: Brief Supportive and Behavioral Treatment

Sponsor

A. Eden Evins

Collaborators

[object Object]
[object Object]